| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 1 | +0.00% | +1.22% | +0.66% | +0.56% | +0.56% | — |
| 14d | 1 | +100.00% | -15.65% | -0.37% | -15.29% | -15.29% | — |
| 30d | 1 | +0.00% | +80.05% | -3.38% | +83.43% | +83.43% | — |
| 60d | 1 | +0.00% | +80.72% | +4.00% | +76.73% | +76.73% | — |
| 90d | 1 | — | — | +8.71% | — | — | — |
| 180d | 1(1 pending) | — | — | — | — | — | — |
| 1y | 1(1 pending) | — | — | — | — | — | — |
| 2y | 1(1 pending) | — | — | — | — | — | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| KURA KURA ONCOLOGY, INC. | PURCHASEGRANT Stock grant | 35,000 | — | — | 35,000 | Jun 4, 2026 | Jun 4, 2026 ↗ | View → |
| DAWN DAY ONE BIOPHARMACEUTICALS, INC. | SALE Head of Research and Dev. | 226,000 | — | — | 0 | Apr 23, 2026 | Apr 23, 2026 ↗ | View → |
| DAWN DAY ONE BIOPHARMACEUTICALS, INC. | SALE Head of Research and Dev. | 4,397 | — | — | 0 | Apr 23, 2026 | Apr 23, 2026 ↗ | View → |
| DAWN DAY ONE BIOPHARMACEUTICALS, INC. | SALE Head of Research and Dev. | 171,000 | — | — | 0 | Apr 23, 2026 | Apr 23, 2026 ↗ | View → |
| DAWN DAY ONE BIOPHARMACEUTICALS, INC. | SALE Head of Research and Dev. | 106,875 | — | — | 0 | Apr 23, 2026 | Apr 23, 2026 ↗ | View → |
| DAWN DAY ONE BIOPHARMACEUTICALS, INC. | SALE Head of Research and Dev. | 346,000 | — | — | 0 | Apr 23, 2026 | Apr 23, 2026 ↗ | View → |
| DAWN DAY ONE BIOPHARMACEUTICALS, INC. | SALE Head of Research and Dev. | 2,728 | $11.60 | $31.6K | 4,397 | Feb 17, 2026 | Feb 18, 2026 ↗ | View → |
| DAWN DAY ONE BIOPHARMACEUTICALS, INC. | PURCHASE Head of Research and Dev. | 7,125 | — | — | 7,125 | Feb 15, 2026 | Feb 18, 2026 ↗ | View → |
| DAWN DAY ONE BIOPHARMACEUTICALS, INC. | SALE Head of Research and Dev. | 7,125 | — | — | 106,875 | Feb 15, 2026 | Feb 18, 2026 ↗ | View → |
| DAWN DAY ONE BIOPHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 171,000 | — | — | 171,000 | Jan 30, 2026 | Jan 30, 2026 ↗ | View → |
| DAWN DAY ONE BIOPHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 114,000 | — | — | 114,000 | Jan 30, 2026 | Jan 30, 2026 ↗ | View → |
| DAWN DAY ONE BIOPHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 346,000 | — | — | 346,000 | Jun 16, 2025 | Jun 18, 2025 ↗ | View → |
| DAWN DAY ONE BIOPHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 226,000 | — | — | 226,000 | Jun 16, 2025 | Jun 18, 2025 ↗ | View → |
| KURA KURA ONCOLOGY, INC. | PURCHASEGRANT Stock grant | 28,500 | — | — | 28,500 | Jun 5, 2025 | Jun 6, 2025 ↗ | View → |
| KURA KURA ONCOLOGY, INC. | PURCHASEGRANT Stock grant | 52,000 | — | — | 52,000 | Sep 13, 2024 | Sep 17, 2024 ↗ | View → |
| KURA KURA ONCOLOGY, INC. | PURCHASEGRANT Stock grant | 17,333 | — | — | 17,333 | Sep 13, 2024 | Sep 17, 2024 ↗ | View → |